📚 Impact 51: Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants (DOACs), A review by Dr. Haeri, Neurologist.

💊 Hypertension and Hyperlipidemia at your fingertips!

5️⃣ H&H Academy in 7 minutes, episode 7.

📚 Impact 50: Thrombolysis before thrombectomy: A bridge not fallen, A review by Dr. Benam, Cardiovascular Specialist.

🫀Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients, by Dr. Bikdeli, Cardiovascular specialist.

SGLT2 inhibitors in CKD: are they really effective in all patients?

DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

23rd ACC 2025 Congress Coverage: FAME 3 Trial

🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.

🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.